LAP2alpha maintains a mobile and low assembly state of A-type lamins in the nuclear interior

Abstract

Lamins form stable filaments at the nuclear periphery in metazoans. Unlike B-type lamins, lamins A and C localize also in the nuclear interior, where they interact with lamin-associated polypeptide 2 alpha (LAP2a). Using antibody labeling, we previously observed a depletion of nucleoplasmic A-type lamins in mouse cells lacking LAP2a. Here we show that loss of LAP2a actually causes formation of larger, biochemically stable lamin A/C structures in the nuclear interior that are inaccessible to lamin A/C antibodies. While nucleoplasmic lamin A forms from newly expressed pre-lamin A during processing and from soluble mitotic lamins in a LAP2a-independent manner, binding of LAP2a to lamins A/C during interphase inhibits formation of higher order structures, keeping nucleoplasmic lamin A/C in a mobile state independent of lamin A/C S22 phosphorylation. We propose that LAP2a is essential to maintain a mobile lamin A/C pool in the nuclear interior, which is required for proper nuclear functions.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2G-H, Figure 4A-B and Figure 6A

Article and author information

Author details

  1. Nana Naetar

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    For correspondence
    nana.naetar@univie.ac.at
    Competing interests
    The authors declare that no competing interests exist.
  2. Konstantina Georgiou

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Christian Knapp

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2463-5775
  4. Irena Bronshtein

    Physics Department and Nanotechnology Institute, Bar Ilan University, Ramt Gan, Israel
    Competing interests
    The authors declare that no competing interests exist.
  5. Elisabeth Zier

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  6. Petra Fichtinger

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  7. Thomas Dechat

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  8. Yuval Garini

    The Mina & Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
    Competing interests
    The authors declare that no competing interests exist.
  9. Roland Foisner

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    For correspondence
    roland.foisner@meduniwien.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4734-4647

Funding

Austrian Science Fund (P26492-B20,P29713-B28,P32512-B)

  • Roland Foisner

Austrian Academy of Sciences (APART 11657)

  • Nana Naetar

Israel Science Foundation (ISF grant 1219/17)

  • Irena Bronshtein
  • Yuval Garini

European Cooperation in Science and Technology (COST-STSM-BM1002-8698,COST-STSM-BM1002-11436)

  • Thomas Dechat

European Molecular Biology Organization (ASTF 316-2011)

  • Thomas Dechat

S Grosskopf Grant

  • Irena Bronshtein
  • Yuval Garini

Austrian Academy of Sciences (ÖAW DOC 25725)

  • Konstantina Georgiou

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Megan C King, Yale School of Medicine, United States

Version history

  1. Received: September 28, 2020
  2. Accepted: February 18, 2021
  3. Accepted Manuscript published: February 19, 2021 (version 1)
  4. Version of Record published: March 8, 2021 (version 2)

Copyright

© 2021, Naetar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,321
    views
  • 307
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nana Naetar
  2. Konstantina Georgiou
  3. Christian Knapp
  4. Irena Bronshtein
  5. Elisabeth Zier
  6. Petra Fichtinger
  7. Thomas Dechat
  8. Yuval Garini
  9. Roland Foisner
(2021)
LAP2alpha maintains a mobile and low assembly state of A-type lamins in the nuclear interior
eLife 10:e63476.
https://doi.org/10.7554/eLife.63476

Share this article

https://doi.org/10.7554/eLife.63476

Further reading

    1. Cell Biology
    Mathieu C Husser, Nhat P Pham ... Alisa Piekny
    Tools and Resources

    Endogenous tags have become invaluable tools to visualize and study native proteins in live cells. However, generating human cell lines carrying endogenous tags is difficult due to the low efficiency of homology-directed repair. Recently, an engineered split mNeonGreen protein was used to generate a large-scale endogenous tag library in HEK293 cells. Using split mNeonGreen for large-scale endogenous tagging in human iPSCs would open the door to studying protein function in healthy cells and across differentiated cell types. We engineered an iPS cell line to express the large fragment of the split mNeonGreen protein (mNG21-10) and showed that it enables fast and efficient endogenous tagging of proteins with the short fragment (mNG211). We also demonstrate that neural network-based image restoration enables live imaging studies of highly dynamic cellular processes such as cytokinesis in iPSCs. This work represents the first step towards a genome-wide endogenous tag library in human stem cells.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Natalia Dolgova, Eva-Maria E Uhlemann ... Oleg Y Dmitriev
    Research Article

    Mediator of ERBB2-driven Cell Motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.